—– This press release has been modified to comply with the Premier IR guidelines —– Lund, Sweden, 13.00 CET, 20 April 2021 – BONESUPPORT™, an emerging leader in orthobiologics for the management of bone injuries, has been awarded a group purchasing agreement for Synthe... read more

REDWOOD CITY, Calif., April 20, 2021 (GLOBE NEWSWIRE) -- Pulmonx Corporation (Nasdaq: LUNG) (“Pulmonx”), a global leader in minimally invasive treatments for lung disease, today announced that it will release financial results for the first quarter of 2021 after the close of trading on Tuesday,... read more

Oslo, Norway, 20 April 2021 Reference is made to the stock exchange announcement on 12 April 2021 regarding the final result of Nordic Nanovector ASA's (OSE: NANOV) (the "Company") the repair offering where 2,699,280 new shares (the "New Shares") were allocated at a subscription price of NOK 22.... read more

2021-04-20 KOL webinar being held on Wednesday, April 28[th] @ 14:00 CET (8 am EST) Gothenburg, April 20, 2021 – Vicore Pharma Holding AB (publ) (“Vicore”), a pharmaceutical company developing innovative medicines for severe lung disorders such as idiopathic pulmonary fibrosis (IPF), today... read more

STOCKHOLM — April 16, 2021 — Oncopeptides AB (publ) (Nasdaq Stockholm: ONCO), a global biotech company focused on the development of therapies for difficult-to-treat hematological diseases, today announces that the Company has submitted an application to the European Medicines Agency,... read more